Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre Zimerman

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Heart Rhythm O2|September 25, 2023
Speech-induced atrial tachycardia: A narrative review of putative mechanisms implicating the autonomic nervous systemGabriel M Pajares Hurtado, John-Ross D Clarke, Andre Zimerman, et al.
Contemporary Clinical Trials|December 15, 2024
Unsupervised clustering approach to assess heterogeneity of treatment effects across patient phenotypes in randomized clinical trialsAndrea Bellavia, Xinhui Ran, Andre Zimerman, et al.
Circulation|April 21, 2025
Intensive Lowering of LDL Cholesterol Levels With Evolocumab in Autoimmune or Inflammatory Diseases: An Analysis of the FOURIER TrialAndre Zimerman, Ana Laura F Kunzler, Brittany N Weber, et al.
American Heart Journal|March 10, 2025
Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemiaNicholas A Marston, Brian A Bergmark, Veronica J Alexander, et al.
American Heart Journal|March 13, 2025
Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence-TIMI 73b trialBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Journal of Clinical Lipidology|December 29, 2023
Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3Andre Zimerman, Stephen D Wiviott, Jeong-Gun Park, et al.
European Journal of Preventive Cardiology|March 14, 2024
Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trialAndre Zimerman, Stephen D Wiviott, Jeong-Gun Park, et al.
Circulation. Cardiovascular Imaging|April 19, 2021
Comparison of Admission Lung Ultrasound and Left Ventricular End-Diastolic Pressure in Patients Undergoing Primary Percutaneous Coronary InterventionGustavo Neves Araujo, Rafael Beltrame, Guilherme Pinheiro Machado, et al.
Arquivos Brasileiros De Cardiologia|March 4, 2026
Brazilian Registry of Pulsed Field Catheter Ablation for the Treatment of Patients with Atrial FibrillationBruna Miers May, Nilson Araujo Junior, Silvia Helena Cardoso Boghossian, et al.
The New England Journal of Medicine|September 1, 2025
Targeting <i>APOC3</i> with Olezarsen in Moderate HypertriglyceridemiaBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Heart Rhythm O2|September 25, 2023
Speech-induced atrial tachycardia: A narrative review of putative mechanisms implicating the autonomic nervous systemGabriel M Pajares Hurtado, John-Ross D Clarke, Andre Zimerman, et al.
Contemporary Clinical Trials|December 15, 2024
Unsupervised clustering approach to assess heterogeneity of treatment effects across patient phenotypes in randomized clinical trialsAndrea Bellavia, Xinhui Ran, Andre Zimerman, et al.
Circulation|April 21, 2025
Intensive Lowering of LDL Cholesterol Levels With Evolocumab in Autoimmune or Inflammatory Diseases: An Analysis of the FOURIER TrialAndre Zimerman, Ana Laura F Kunzler, Brittany N Weber, et al.
American Heart Journal|March 10, 2025
Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemiaNicholas A Marston, Brian A Bergmark, Veronica J Alexander, et al.
American Heart Journal|March 13, 2025
Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence-TIMI 73b trialBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Journal of Clinical Lipidology|December 29, 2023
Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3Andre Zimerman, Stephen D Wiviott, Jeong-Gun Park, et al.
European Journal of Preventive Cardiology|March 14, 2024
Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trialAndre Zimerman, Stephen D Wiviott, Jeong-Gun Park, et al.
Circulation. Cardiovascular Imaging|April 19, 2021
Comparison of Admission Lung Ultrasound and Left Ventricular End-Diastolic Pressure in Patients Undergoing Primary Percutaneous Coronary InterventionGustavo Neves Araujo, Rafael Beltrame, Guilherme Pinheiro Machado, et al.
Arquivos Brasileiros De Cardiologia|March 4, 2026
Brazilian Registry of Pulsed Field Catheter Ablation for the Treatment of Patients with Atrial FibrillationBruna Miers May, Nilson Araujo Junior, Silvia Helena Cardoso Boghossian, et al.
The New England Journal of Medicine|September 1, 2025
Targeting <i>APOC3</i> with Olezarsen in Moderate HypertriglyceridemiaBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
Pageof 2